Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Total
Balances at beginning (in shares) at Mar. 31, 2018 500,000 1,160,240 2,318,012 23,068,280        
Balances at beginning at Mar. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 23,100 $ 16,740,400 $ (3,968,100) $ (156,543,800) $ 6,916,600
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings (in shares)       40,000        
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings         50,000     50,000
Proceeds from exercise of warrants (in shares)       5,000        
Proceeds from exercise of warrants         7,500     7,500
Accrued dividends on Series B Preferred stock         (273,500)     (273,500)
Stock-based compensation expense         612,600     612,600
Fair value of common stock issued for services (in shares)       100,000        
Fair value of common stock issued for services       $ 100 122,900     123,000
Net loss (4,214,500) (4,214,500)
Balances at end (in shares) at Jun. 30, 2018 500,000 1,160,240 2,318,012 23,213,280        
Balances at end at Jun. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 23,200 167,920,900 (3,968,100) (160,758,300) 3,221,700
Balances at beginning (in shares) at Mar. 31, 2018 500,000 1,160,240 2,318,012 23,068,280        
Balances at beginning at Mar. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 23,100 16,740,400 (3,968,100) (156,543,800) 6,916,600
Proceeds from exercise of warrants               605,700
Balances at end (in shares) at Dec. 31, 2018 500,000 1,160,240 2,318,012 31,204,380        
Balances at end at Dec. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 31,200 181,035,800 (3,968,100) (175,410,100) 1,692,800
Balances at beginning (in shares) at Jun. 30, 2018 500,000 1,160,240 2,318,012 23,213,280        
Balances at beginning at Jun. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 23,200 167,920,900 (3,968,100) (160,758,300) 3,221,700
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings (in shares)       3,783,000        
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings       $ 3,800 4,725,000     4,728,800
Accrued dividends on Series B Preferred stock         (283,600)     (283,600)
Stock-based compensation expense         1,172,400     1,172,400
Fair value of common stock issued for license (in shares)       1,630,435        
Fair value of common stock issued for license       $ 1,600 2,248,400     2,250,000
Fair value of common stock issued for services (in shares)       50,000        
Fair value of common stock issued for services       $ 100 334,800     334,900
Net loss (7,435,000) (7,435,000)
Balances at end (in shares) at Sep. 30, 2018 500,000 1,160,240 2,318,012 28,676,715        
Balances at end at Sep. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 28,700 176,117,900 (3,968,100) (168,193,300) 3,989,200
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings (in shares)       1,202,939        
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings       $ 1,200 1,851,400     1,852,600
Proceeds from exercise of warrants (in shares)       398,800        
Proceeds from exercise of warrants       $ 400 597,800     598,200
Accrued dividends on Series B Preferred stock         (290,900)     (290,900)
Stock-based compensation expense         734,700     734,700
Fair value of common stock issued for license (in shares)       925,926        
Fair value of common stock issued for license       $ 900 1,999,100     2,000,000
Increase in fair value attributed to warrant modifications and additional warrants issued         25,800     25,800
Net loss (7,216,800) (7,216,800)
Balances at end (in shares) at Dec. 31, 2018 500,000 1,160,240 2,318,012 31,204,380        
Balances at end at Dec. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 31,200 181,035,800 (3,968,100) (175,410,100) 1,692,800
Balances at beginning (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,129,900 (3,968,100) (181,133,400) 7,075,200
Accrued dividends on Series B Preferred stock         (302,500)     (302,500)
Stock-based compensation expense         1,063,000     1,063,000
Net loss (6,209,900) (6,209,900)
Balances at end (in shares) at Jun. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at end at Jun. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,890,400 (3,968,100) (187,343,300) 1,625,800
Balances at beginning (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,129,900 (3,968,100) (181,133,400) 7,075,200
Proceeds from exercise of warrants               410,000
Balances at end (in shares) at Dec. 31, 2019 500,000 1,160,240 2,318,012 44,228,630        
Balances at end at Dec. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 44,200 196,466,000 (3,968,100) (198,640,700) (6,094,600)
Balances at beginning (in shares) at Jun. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Jun. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,890,400 (3,968,100) (187,343,300) 1,625,800
Accrued dividends on Series B Preferred stock         (313,800)     (313,800)
Stock-based compensation expense         775,400     775,400
Net loss (5,717,900) (5,717,900)
Balances at end (in shares) at Sep. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at end at Sep. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 193,352,000 (3,968,100) (193,061,200) (3,630,400)
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings (in shares)       650,000        
Proceeds from sale of common stock and warrants for cash and settlement of professional services payable in private placement offerings       $ 600 649,400     650,000
Proceeds from sale of warrants in private placement         300,000     300,000
Proceeds from exercise of warrants (in shares)       820,000        
Proceeds from exercise of warrants       $ 800 409,200     410,000
Accrued dividends on Series B Preferred stock         (321,800)     (321,800)
Stock-based compensation expense         1,632,200     1,632,200
Increase in fair value attributed to warrant modifications and additional warrants issued         826,900     826,900
Net loss (5,961,500) (5,961,500)
Balances at end (in shares) at Dec. 31, 2019 500,000 1,160,240 2,318,012 44,228,630        
Balances at end at Dec. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 44,200 $ 196,466,000 $ (3,968,100) $ (198,640,700) $ (6,094,600)